The Macular Society has reported on groundbreaking stem cell treatment for people with wet age-related macular disease.
Patients who were the first to receive a new treatment for wet age-related macular degeneration (AMD) derived from stem cells in 2015 have maintained improvements in their vision five years on.
Five years since the trial started, eye-researcher Professor Pete Coffey has confirmed the patients have maintained the improvements in their vision.
Before receiving the treatment the first patient was reading at a speed of one and a half words per minute, but after the operation is able to read up to 80 words a minute. The second patient, who couldn’t read at all before the procedure, is now reading up to 50 words a minute.
Prof. Coffey said the results had far surpassed their expectations and after the UK eases out of lockdown they are ready to treat the next round of patients in the trial.
While it is currently being trialled in patients with wet AMD it is hoped that in the future it will could be used to treat dry AMD – and potentially other types of macular disease.